Control del recuento de células somáticas (RCS) en leche ovina mediante test de California (CMT) y secado selectivo

  1. González-Montaña, J.R. 1
  2. Ávila, S. 2
  3. Alonso, A.J. 1
  4. Alonso, M.E. 1
  5. Alonso, M.P. 1
  6. Martín, M.J. 1
  7. Martínez-Pastor, F. 1
  8. Martín, B. 1
  9. Domínguez, J.C 1
  1. 1 Universidad de León

    Universidad de León

    León, España


  2. 2 Universidad Nacional Autónoma de México

    Universidad Nacional Autónoma de México

    Ciudad de México, México


XLIII Congreso Nacional y XIX Congreso Internacional de la Sociedad Española de Ovinotecnia y Caprinotecnia (SEOC)
  1. María Jesús Alcalde Aldea (coord.)
  2. Begoña Panea Doblado (coord.)
  3. Valentín Pérez Pérez (coord.)
  4. Raúl Bodas Rodríguez (coord.)
  5. Francisco Saura Armelles (coord.)
  6. Juan José Ramos Antón (coord.)

Publisher: Sociedad Española de Ovinotecnia y Caprinotecnia SEOC

ISBN: 978-84-697-5289-0

Year of publication: 2018

Pages: 283-290

Congress: Sociedad Española de Ovinotecnia y Caprinotecnia (SEOC). Jornadas (43. 2018. Zaragoza)

Type: Conference paper


With the aim of improving the quality of milk in a sheep farm with a high somatic cell count (CCS) and some cases of subclinical mastitis, we have identified the risk points and suggested some alternatives. Three California Mastitis Tests (CMT1, CMT2 and CMT3) were performed on all lactating sheep, and milk samples were collected for bacteriological identification and antibiogram. The measures to be taken were based on the degree of mammary affectation, the number of udders affected, the moment of lactation and the productive quality of the sheep, and included: removal of animal, immediate antibiotic treatment, treatment by means of drying cannula, or even no action. The number of affected animals decreased considerably, and it was only necessary to treat with immediate antibiotherapy to 11.9% of ewe, and between 10.8% and 4.8% of ewe in drying therapy. The majority of ewes did not need drying therapy. There was a significant decrease in SCC and bacteriology throughout the trial, with values of 1214 × 103 CCS/mL and 114000 bacteria/ml up to 559000 CCS/mL and 40000 bacteria/mL, after the proposed measures.